What’s more, in HCC, over-expression of ASPH also resulted in its invasiveness and augmented hydroxylase activity of tumor tissues was associated with unfavorable prognoses of patients with HCC [41]. The gene discussed is ASPH; the disease is hepatocellular carcinoma.